EU collaboration strengthens safety monitoring of medicines
European Commission publishes three-year report on implementation ofpharmacovigilance legislation
Closer collaboration between the European Medicines Agency (EMA), the European Commission and the EU Member States, enabled by the new Europeanpharmacovigilance legislation, has enhanced the monitoring of the safety of human medicines throughout their life cycle, for the benefit of patients. This is highlighted in theEuropean Commission report on the pharmacovigilance activities of the European medicines regulatory network published today.
Click on this link for more information.
